NCT03237936View on ClinicalTrials.gov

Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

July 11, 2018

Study Completion Date

July 11, 2018

Conditions
Keratitis
Interventions
DRUG

1mg/mL ciclosporin

IKERVIS® (1mg/ml ciclosporin) eye drops administered once daily following 3 months of treatment

Trial Locations (1)

Unknown

CHU de Brest, Brest

All Listed Sponsors
lead

Santen SAS

INDUSTRY

NCT03237936 - Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis | Biotech Hunter | Biotech Hunter